(MENAFN- GlobeNewsWire - Nasdaq) The growth of the Patient Generated Health Data market offers key opportunities in remote monitoring, personalized medicine, and chronic disease management. With rising wearables adoption, data integration into electronic health records, and supportive regulatory frameworks, regions like North America and Asia-Pacific lead expansion.

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Patient Generated Health Data - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Patient Generated Health Data was estimated at US$5.2 Billion in 2024 and is projected to reach US$7.5 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Patient Generated Health Data market.

Growth in the patient generated health data market is driven by factors such as rising adoption of wearable technologies, increasing focus on personalized medicine, and growing demand for continuous health monitoring. Advances in sensor miniaturization, mobile connectivity, and health tracking algorithms are enabling reliable, user-friendly data collection across varied demographics.
Regulatory frameworks supporting remote care reimbursement and digital health record integration are encouraging healthcare providers to include PGHD in routine care management. Chronic disease monitoring, post-discharge care, and wellness tracking are creating high-utility application areas for PGHD. Enhanced patient awareness and self-management behaviors are further contributing to data richness, making PGHD a key input for population health analytics, risk stratification, and proactive care delivery models.
What Is Patient Generated Health Data and Why Is It Valuable in Clinical Decision Making?
Patient generated health data (PGHD) refers to health-related data created, recorded, or gathered by individuals outside traditional clinical settings, often through wearables, mobile apps, or self-reported inputs. This data includes information on symptoms, lifestyle behaviors, biometric readings, treatment adherence, and quality of life metrics. Unlike data captured during hospital visits or lab tests, PGHD provides continuous, real-time insights into a patient's day-to-day health status.
The use of PGHD is transforming patient monitoring and personalized care delivery, particularly in chronic disease management and preventive health. It fills important gaps between clinical encounters, offering clinicians a more holistic view of patient progress and behavior. As healthcare moves toward outcome-based models, the inclusion of PGHD in care planning is improving responsiveness, early intervention, and patient-provider collaboration.
How Are Devices, Platforms, and Standards Evolving to Support PGHD Collection and Use?
Technological advancements are enhancing the scope, accuracy, and usability of PGHD. Wearable devices now monitor a wide range of parameters including heart rate, glucose levels, sleep patterns, and activity levels with medical-grade precision. Smartphone applications are allowing users to track medication intake, mood, and dietary habits. Voice recognition tools and smart home devices are also contributing to passive data capture in patient-friendly formats.
To make PGHD clinically relevant, platforms are being developed to integrate this data into electronic health records in structured, interpretable formats. Standardized APIs and data governance frameworks are improving data security, interoperability, and consent management. Clinical algorithms and dashboards are being designed to filter, prioritize, and visualize PGHD for physicians, enabling them to respond to meaningful changes without being overwhelmed by raw data.
Where Is PGHD Adoption Expanding and Which Use Cases Are Leading Application?
PGHD adoption is growing across healthcare systems, wellness programs, remote patient monitoring services, and clinical research. North America and Europe are leading in infrastructure readiness and regulatory support for patient-driven data use. Asia-Pacific is catching up rapidly as wearables and health apps become more affordable and accessible to broad segments of the population.
Use cases are expanding across conditions such as diabetes, cardiovascular disease, mental health, oncology, and respiratory illness. Remote patient monitoring programs rely on PGHD to detect early warning signs and reduce hospital admissions. In clinical trials, patient-reported outcomes and real-time biometrics are improving data accuracy and participant retention. Insurance providers are also utilizing PGHD to tailor wellness incentives and assess risk profiles with greater precision.

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as AliveCor Inc., Allscripts Healthcare Solutions, Apple Inc., Athenahealth Inc., Cerner Corporation and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Fitness & Wellness Data segment, which is expected to reach US$3.3 Billion by 2030 with a CAGR of a 8.0%. The Disease Management Data segment is also set to grow at 4.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $1.4 Billion in 2024, and China, forecasted to grow at an impressive 10.0% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Segments:

• Data Type (Fitness & Wellness Data, Disease Management Data, Remote Monitoring Data, Other Data Types)
• End-Use (Hospitals & Clinics End-Use, Research Centers End-Use, Healthcare Payers End-Use, Other End-Uses)

Key Attributes:

Report Attribute	Details
No. of Pages	277
Forecast Period	2024 - 2030
Estimated Market Value in 2024	5.2 Billion
Forecasted Market Value by 2030	7.5 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global

Key Topics Covered:
MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Tariff Impact on Global Supply Chain Patterns
• Patient Generated Health Data - Global Key Competitors Percentage Market Share in 2025 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)

MARKET TRENDS & DRIVERS

• Rising Demand for Personalized and Preventive Care Models Spurs Integration of Patient Generated Health Data (PGHD)
• Expansion of Wearable Devices and Mobile Health Apps Strengthens Data Flow From Patients to Providers
• Shift Toward Remote Monitoring and Home-Based Care Throws the Spotlight on Real-Time PGHD for Clinical Decision Support
• Government and Payer Incentives for Chronic Disease Management Encourage Use of PGHD for Outcome-Based Care
• Advancements in Interoperability and API Integration Improve EMR Compatibility With External Health Data Sources
• Surge in Consumer Awareness and Digital Health Literacy Supports Active Health Tracking and Data Sharing Behavior
• Growing Role of AI and Data Analytics Enables Derivation of Actionable Insights From Unstructured PGHD
• Development of Condition-Specific Tracking Tools Enhances Monitoring of Diabetes, Cardiac Conditions, and Mental Health
• Patient Empowerment Movements Promote Active Participation in Health Management Through Data Contribution
• Concerns Over Data Accuracy and Standardization Encourage Investment in Structured Input Tools and Validation Algorithms
• Integration With Population Health Platforms Enhances Cohort Monitoring and Predictive Modeling

FOCUS ON SELECT PLAYERS | Some of the 34 companies featured in this Patient Generated Health Data market report

• AliveCor Inc.
• Allscripts Healthcare Solutions
• Apple Inc.
• Athenahealth Inc.
• Cerner Corporation
• Dexcom Inc.
• Epic Systems Corporation
• Fitbit Inc.
• HealthMine Inc.
• Livongo Health (now part of Teladoc)
• Medidata Solutions
• Medtronic plc
• Noom Inc.
• Omada Health Inc.
• PatientLikeMe
• Propeller Health
• WellDoc Inc.
• Luscii (Omron)
• Athelas
• Kwido

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Patient Generated Health Data Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN24072025004107003653ID1109841986